Crohn's disease and hyperbaric oxygen therapy

20Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

PURPOSE: Evaluate the application of Hyperbaric Oxygen Therapy (HBO) in patients with Crohn's disease (CD) refractory to pharmacologic therapy, who developed abdominal, anorectal or skin complications. METHODS: Fourteen selected patients with refractory CD and treated at the School of Medicine of Ribeirao Preto, University of Sao Paulo (FMRP-USP) and at the Center of Hyperbaric Medicine, São Paulo Hospital (CEMEHI) were submitted to HBO. RESULTS: Of the 14 patients evaluated, 11 had a satisfactory response. CONCLUSION: HBO has shown benefits in patients with CD refractory to pharmacologic therapy.

Cite

CITATION STYLE

APA

Iezzi, L. E., Feitosa, M. R., Medeiros, B. A., Aquino, J. C., de Almeida, A. L. N. R., Parra, R. S., … Féres, O. (2011). Crohn’s disease and hyperbaric oxygen therapy. Acta Cirurgica Brasileira, 26(SUPPL. 2), 130–132. https://doi.org/10.1590/s0102-86502011000800024

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free